| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1-O-R) and T-like Antigens: A Comparative Study Using Peanut Agglutinin and Poly- and Monoclonal Antibodies1
Department of Experimental Clinical Oncology, The Danish Cancer Society [N. C. L., T. F. Ø.], Department of Urology, Skejby Hospital [N. C. L., H. W.], and the Royal Dental College [H. C.], Copenhagen; and University Department of Clinical Chemistry, Aarhus Municipal Hospital [T. F. Ø.], Aarhus, Denmark
T- and T-like antigens on glycoproteins and glycolipids were examined in extracts of human urinary bladder tumors and normal tissue by Western blot analysis and reagent binding to thin layer chromatograms. Three different anti-T-reagents were used: peanut (Arachis hypogaea) lectin (PNA) and mono- and polyclonal antibodies specific for T-antigen (Galß(13)GalNAc
1-O-R).
Immunodetection with the T-specific reagents in nitrocellulose replicas of bladder tumor glycoproteins, separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, demonstrated tumor-specific T-antigen-bearing glycoproteins compared to normal urothelial glycoproteins. In addition, a remarkable difference in binding was found between the immunological reagents and PNA lectin. PNA showed major reactivity to a 28-kD glycoprotein extracted from tumors. Monoclonal anti-T-antibody (clone HH8) showed major reactivity with an Mr 34,000 glycoprotein, and polyclonal anti-T-antibody showed major reactivity with an Mr 36,000 glycoprotein. PNA agarose column affinity-purified tumor glycoproteins did not bind the antibodies. Glycoproteins, Mr 28,000 and 34,000, were shown to be O-linked by stepwise deglycosylation. In solid phase monosaccharide inhibition tests, galactose followed by N-acetyl-galactosamine were the most potent monosaccharides inhibiting binding to immobilized bladder tumor glycoproteins. None of the anti-T-reagents reacted with glycolipids extracted from tumor tissue. It is concluded that PNA lectin, in addition to the T-disaccharide, reacts with other protein-anchored carbohydrate structures in carcinomas.
1 The study was supported by grants from the Danish Cancer Society (N. C. L., T. F. Ø.), the Department of Clinical Research, the University of Aarhus (N. C. L., H. W.), and Ingeniør August Frederik Wedell Erichsens Foundation (N. C. L.).
2 To whom reprint requests should be addressed, at the Danish Cancer Society, Department of Experimental and Clinical Oncology, Nørrebrogade 44, DK-8000 Aarhus C, Denmark.
Received 3/25/92. Accepted 7/ 8/92.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |